Cancer and Orofacial Pain

Oral and Maxillofacial Surgery Clinics of North America

Volumn 20, Issue 2, 2008, Pages 287-301

  Fischer, Dena J ^a   Klasser, Gary D ^a   Epstein, Joel B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADJUVANT THERAPY; BONE NECROSIS; CHRONIC DISEASE; FACE PAIN; HEAD AND NECK TUMOR; HUMAN; METASTASIS; OPPORTUNISTIC INFECTION; REFERRED PAIN; REVIEW; TRISMUS;

ACUTE DISEASE; CHRONIC DISEASE; FACIAL PAIN; HEAD AND NECK NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; OPPORTUNISTIC INFECTIONS; OSTEONECROSIS; PAIN, REFERRED; TRISMUS;

EID: 40649127718     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2007.12.011     Document Type: Review

References (149)

1. Portenoy R.K., and Lesage P. Management of cancer pain. Lancet 353 9165 (1999) 1695-1700
2. Caraceni A., and Portenoy R.K. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82 3 (1999) 263-274
3. Grond S., Zech D., Diefenbach C., et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64 1 (1996) 107-114
4. Portenoy R.K. Pain and quality of life: clinical issues and implications for research. Oncology (Williston Park) 4 5 (1990) 172-178 [discussion: 94]
5. Gorsky M., Epstein J.B., Oakley C., et al. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 5 (2004) 546-552
6. Cuffari L., Tesseroli de Siqueira J.T., Nemr K., et al. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 1 (2006) 56-61
7. Terhaard C.H., Lubsen H., Van der Tweel I., et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26 8 (2004) 681-692 [discussion: 92-3]
8. Boerman R.H., Maassen E.M., Joosten J., et al. Trigeminal neuropathy secondary to perineural invasion of head and neck carcinomas. Neurology 53 1 (1999) 213-216
9. Epstein J.B., and Jones C.K. Presenting signs and symptoms of nasopharyngeal carcinoma. Oral Surg Oral Med Oral Pathol 75 1 (1993) 32-36
10. Reiter S., Gavish A., Winocur E., et al. Nasopharyngeal carcinoma mimicking a temporomandibular disorder: a case report. J Orofac Pain 20 1 (2006) 74-81
11. Cohen S.G., and Quinn P.D. Facial trismus and myofascial pain associated with infections and malignant disease. Report of five cases. Oral Surg Oral Med Oral Pathol 65 5 (1988) 538-544
12. Hauser M.S., and Boraski J. Oropharyngeal carcinoma presenting as an odontogenic infection with trismus. Oral Surg Oral Med Oral Pathol 61 4 (1986) 330-332
13. Chen M.S., Lin F.J., Tang S.G., et al. Clinical significance of cranial nerve deficit in the therapy of nasopharyngeal carcinoma. Br J Radiol 62 740 (1989) 739-743
14. Skinner D.W., and Van Hasselt C.A. Nasopharyngeal carcinoma: methods of presentation. Ear Nose Throat J 69 4 (1990) 237-240
15. Bennett J.H., Thomas G., Evans A.W., et al. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 3 (2000) 323-332
16. Gorsky M., and Epstein J.B. Craniofacial osseous and chondromatous sarcomas in British Columbia-a review of 34 cases. Oral Oncol 36 1 (2000) 27-31
17. Mardinger O., Givol N., Talmi Y.P., et al. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 4 (2001) 445-451
18. Cheng T.M., Cascino T.L., and Onofrio B.M. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 43 11 (1993) 2298-2302
19. Bullitt E., Tew J.M., and Boyd J. Intracranial tumors in patients with facial pain. J Neurosurg 64 6 (1986) 865-871
20. Vogelsang G.B., Lee L., and Bensen-Kennedy D.M. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 54 (2003) 29-52
21. Christiaans M.H., Kelder J.C., Arnoldus E.P., et al. Prediction of intracranial metastases in cancer patients with headache. Cancer 94 7 (2002) 2063-2068
22. Hirshberg A., and Buchner A. Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol 31B 6 (1995) 355-360
23. D'Silva N.J., Summerlin D.J., Cordell K.G., et al. Metastatic tumors in the jaws: a retrospective study of 114 cases. J Am Dent Assoc 137 12 (2006) 1667-1672
24. Hirshberg A., Leibovich P., and Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med 22 9 (1993) 385-390
25. Hirshberg A., Leibovich P., and Buchner A. Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med 23 8 (1994) 337-341
26. DePena C.A., Van Tassel P., and Lee Y.Y. Lymphoma of the head and neck. Radiol Clin North Am 28 4 (1990) 723-743
27. Epstein J.B., Epstein J.D., Le N.D., et al. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 5 (2001) 519-525
28. American Cancer Society. Cancer facts & figures 2007 (2007), American Cancer Society, Inc., Atlanta (GA)
29. Jacobs C., Weiss L., and Hoppe R.T. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg 112 6 (1986) 654-658
30. Barrett A.P. Leukemic cell infiltration of the gingivae. J Periodontol 57 9 (1986) 579-581
31. Witt C., Borges A.C., Klein K., et al. Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients. J Oral Maxillofac Surg 55 5 (1997) 450-453 [discussion: 54-5]
32. Epstein J.B., Voss N.J., and Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 57 3 (1984) 267-271
33. Abraham P.J., Capobianco D.J., and Cheshire W.P. Facial pain as the presenting symptom of lung carcinoma with normal chest radiograph. Headache 43 5 (2003) 499-504
34. Bindoff L.A., and Heseltine D. Unilateral facial pain in patients with lung cancer: a referred pain via the vagus?. Lancet 1 8589 (1988) 812-815
35. Capobianco D.J. Facial pain as a symptom of nonmetastatic lung cancer. Headache 35 10 (1995) 581-585
36. Eross E.J., Dodick D.W., Swanson J.W., et al. A review of intractable facial pain secondary to underlying lung neoplasms. Cephalalgia 23 1 (2003) 2-5
37. Sarlani E., Schwartz A.H., Greenspan J.D., et al. Facial pain as first manifestation of lung cancer: a case of lung cancer-related cluster headache and a review of the literature. J Orofac Pain 17 3 (2003) 262-267
38. Shih A., Miaskowski C., Dodd M.J., et al. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. Oncol Nurs Forum 29 7 (2002) 1063-1080
39. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34 1 (1998) 39-43
40. Peterson D.E. Research advances in oral mucositis. Curr Opin Oncol 11 4 (1999) 261-266
41. Woo S.B., Sonis S.T., Monopoli M.M., et al. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72 5 (1993) 1612-1617
42. Jansma J., Vissink A., Bouma J., et al. A survey of prevention and treatment regimens for oral sequelae resulting from head and neck radiotherapy used in Dutch radiotherapy institutes. Int J Radiat Oncol Biol Phys 24 2 (1992) 359-367
43. Elting L.S., Cooksley C., Chambers M., et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98 7 (2003) 1531-1539
44. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 19 (2004) 1945-1952
45. Epstein J.B., Robertson M., Emerton S., et al. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23 5 (2001) 389-398
46. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66 3 (2003) 253-262
47. Elting L.S., Cooksley C.D., Chambers M.S., et al. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68 4 (2007) 1110-1120
48. Epstein J.B., Emerton S., Kolbinson D.A., et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21 1 (1999) 1-11
49. Epstein J.B., and Stewart K.H. Radiation therapy and pain in patients with head and neck cancer. Eur J Cancer B Oral Oncol 29B 3 (1993) 191-199
50. Anderson P.M., Schroeder G., and Skubitz K.M. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83 7 (1998) 1433-1439
51. McGuire D.B., Correa M.E., Johnson J., et al. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14 6 (2006) 541-547
52. Rubenstein E.B., Peterson D.E., Schubert M., et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 Suppl 9 (2004) 2026-2046
53. Tombes M.B., and Gallucci B. The effects of hydrogen peroxide rinses on the normal oral mucosa. Nurs Res 42 6 (1993) 332-337
54. Clarkson J., Worthington H., and Eden O. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2 (2007) CD001973
55. Worthington H.V., Clarkson J.E., and Eden O.B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 4 (2006) CD000978
56. Akintoye S.O., Brennan M.T., Graber C.J., et al. A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 5 (2002) 581-588
57. Graber C.J., de Almeida K.N., Atkinson J.C., et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27 5 (2001) 537-542
58. Peters E., Monopoli M., Woo S.B., et al. Assessment of the need for treatment of postendodontic asymptomatic periapical radiolucencies in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 76 1 (1993) 45-48
59. Sonis S.T., Peterson D.E., McGuire D.B., et al. Prevention of mucositis in cancer patients. J Natl Cancer Inst Monogr 29 (2001) 1-2
60. Kennedy H.F., Morrison D., Kaufmann M.E., et al. Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. J Med Microbiol 49 4 (2000) 367-370
61. Raber-Durlacher J.E., Epstein J.B., Raber J., et al. Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10 6 (2002) 466-473
62. Peterson D.E. Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 9 (1990) 61-71
63. Sonis S.T., Woods P.D., and White B.A. Oral complications of cancer therapies. Pretreatment oral assessment. NCI Monogr 9 (1990) 29-32
64. Epstein J.B., and Chow A.W. Oral complications associated with immunosuppression and cancer therapies. Infect Dis Clin North Am 13 4 (1999) 901-923
65. Donnelly J.P. Infection in the neutropenic and haematopoietic stem cell transplant recipient. Curr Opin Infect Dis 13 4 (2000) 337-342
66. Bohme A., Karthaus M., and Hoelzer D. Antifungal prophylaxis in neutropenic patients with hematologic malignancies. Antibiot Chemother 50 (2000) 69-78
67. Schubert M.M., Peterson D.E., Flournoy N., et al. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 70 3 (1990) 286-293
68. Schubert M.M. Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent 1 4 (1991) 384-397
69. Samonis G., Mantadakis E., and Maraki S. Orofacial viral infections in the immunocompromised host. Oncol Rep 7 6 (2000) 1389-1394
70. Lloid M.E., Schubert M.M., Myerson D., et al. Cytomegalovirus infection of the tongue following marrow transplantation. Bone Marrow Transplant 14 1 (1994) 99-104
71. Schubert M.M., Epstein J.B., Lloid M.E., et al. Oral infections due to cytomegalovirus in immunocompromised patients. J Oral Pathol Med 22 6 (1993) 268-273
72. Kanegane H., Nomura K., Miyawaki T., et al. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol 44 3 (2002) 239-249
73. Epstein J.B., Gorsky M., Hancock P., et al. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 6 (2002) 712-716
74. Mandanas RA. Graft versus host disease. 2007. Available at: www.emedicine.com. Accessed May 31, 2007.
75. Schubert M.M., and Sullivan K.M. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 9 (1990) 135-143
76. Woo S.B., Lee S.J., and Schubert M.M. Graft-vs.-host disease. Crit Rev Oral Biol Med 8 2 (1997) 201-216
77. Sonis S.T., and Fey E.G. Oral complications of cancer therapy. Oncology (Williston Park) 16 5 (2002) 680-686 [discussion: 86, 91-2, 95]
78. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 12 1 (2006) 31-47
79. Abdelsayed R.A., Sumner T., Allen C.M., et al. Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 1 (2002) 75-80
80. IASP Taskforce on Taxonomy. Classification of chronic pain. 2nd edition (1994), IASP Press, Seattle (WA)
81. Coderre T.J., Katz J., Vaccarino A.L., et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 3 (1993) 259-285
82. Chow H.T., and Teh L.Y. Sensory impairment after resection of the mandible: a case report of 10 cases. J Oral Maxillofac Surg 58 6 (2000) 629-635
83. Rogers S.N., Lowe D., McNally D., et al. Health-related quality of life after maxillectomy: a comparison between prosthetic obturation and free flap. J Oral Maxillofac Surg 61 2 (2003) 174-181
84. Terrell J.E., Nanavati K., Esclamado R.M., et al. Health impact of head and neck cancer. Otolaryngol Head Neck Surg 120 6 (1999) 852-859
85. Sist T., Miner M., and Lema M. Characteristics of postradical neck pain syndrome: a report of 25 cases. J Pain Symptom Manage 18 2 (1999) 95-102
86. van Wilgen C.P., Dijkstra P.U., van der Laan B.F., et al. Morbidity of the neck after head and neck cancer therapy. Head Neck 26 9 (2004) 785-791
87. Talmi Y.P., Horowitz Z., Pfeffer M.R., et al. Pain in the neck after neck dissection. Otolaryngol Head Neck Surg 123 3 (2000) 302-306
88. Chua K.S., Reddy S.K., Lee M.C., et al. Pain and loss of function in head and neck cancer survivors. J Pain Symptom Manage 18 3 (1999) 193-202
89. Dougherty P.M., Cata J.P., Cordella J.V., et al. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109 1-2 (2004) 132-142
90. Mielke S., Sparreboom A., and Moss K. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 42 1 (2006) 24-30
91. Mantyh P.W. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7 10 (2006) 797-809
92. Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 23 (2004) 2343-2351
93. Chaudhry V., Rowinsky E.K., Sartorius S.E., et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35 3 (1994) 304-311
94. Burton A.W., Fanciullo G.J., Beasley R.D., et al. Chronic pain in the cancer survivor: a new frontier. Pain Med 8 2 (2007) 189-198
95. Visovsky C. Chemotherapy-induced peripheral neuropathy. Cancer Invest 21 3 (2003) 439-451
96. Postma T.J., Vermorken J.B., Liefting A.J., et al. Paclitaxel-induced neuropathy. Ann Oncol 6 5 (1995) 489-494
97. Verstappen C.C., Postma T.J., Hoekman K., et al. Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer. J Neurooncol 63 2 (2003) 201-205
98. Vissink A., Jansma J., Spijkervet F.K., et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14 3 (2003) 199-212
99. Small Jr. W., and Kachnic L. Postradiotherapy pelvic fractures: cause for concern or opportunity for future research?. JAMA 294 20 (2005) 2635-2637
100. New P. Radiation injury to the nervous system. Curr Opin Neurol 14 6 (2001) 725-734
101. Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85 1 (2007) 156-170
102. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 5 (2000) 1311-1322
103. Ruo Redda M.G., and Allis S. Radiotherapy-induced taste impairment. Cancer Treat Rev 32 7 (2006) 541-547
104. Chambers M.S., Garden A.S., Kies M.S., et al. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 26 9 (2004) 796-807
105. Jensen S.B., Pedersen A.M., Reibel J., et al. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11 4 (2003) 207-225
106. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 9 Suppl 2 (2005) S84-S91
107. Conger A.D. Loss and recovery of taste acuity in patients irradiated to the oral cavity. Radiat Res 53 2 (1973) 338-347
108. Maes A., Huygh I., Weltens C., et al. De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy. Radiother Oncol 63 2 (2002) 195-201
109. Mossman K.L. Gustatory tissue injury in man: radiation dose response relationships and mechanisms of taste loss. Br J Cancer Suppl 7 (1986) 9-11
110. Tomita Y., and Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 19 5 (1990) 299-304
111. Marx R.E., and Johnson R.P. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64 4 (1987) 379-390
112. Myers R.A., and Marx R.E. Use of hyperbaric oxygen in postradiation head and neck surgery. NCI Monogr 9 (1990) 151-157
113. Epstein J., van der Meij E., McKenzie M., et al. Postradiation osteonecrosis of the mandible: a long-term follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 6 (1997) 657-662
114. Jereczek-Fossa B.A., and Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28 1 (2002) 65-74
115. Epstein J.B., Wong F.L., and Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 45 2 (1987) 104-110
116. Reuther T., Schuster T., Mende U., et al. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32 3 (2003) 289-295
117. Fleisch H. Development of bisphosphonates. Breast Cancer Res 4 1 (2002) 30-34
118. Sato M., Grasser W., Endo N., et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88 6 (1991) 2095-2105
119. Xing L., and Boyce B.F. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun 328 3 (2005) 709-720
120. Sietsema W.K., Ebetino F.H., Salvagno A.M., et al. Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Exp Clin Res 15 9 (1989) 389-396
121. Licata A.A. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother 39 4 (2005) 668-677
122. Ott S.M. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90 3 (2005) 1897-1899
123. Fournier P., Boissier S., Filleur S., et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62 22 (2002) 6538-6544
124. Wood J., Bonjean K., Ruetz S., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 3 (2002) 1055-1061
125. Marx R.E., Sawatari Y., Fortin M., et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 11 (2005) 1567-1575
126. Migliorati C.A., Schubert M.M., Peterson D.E., et al. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 1 (2005) 83-93
127. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 34 (2005) 8580-8587
128. Dimopoulos M.A., Kastritis E., Anagnostopoulos A., et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 91 7 (2006) 968-971
129. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 10 (2006) 753-761
130. Migliorati C.A., Casiglia J., Epstein J., et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136 12 (2005) 1658-1668
131. Magopoulos C., Karakinaris G., Telioudis Z., et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28 3 (2007) 158-163
132. Adornato M.C., Morcos I., and Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138 7 (2007) 971-977
133. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 5 (2004) 527-534
134. Freiberger J.J., Padilla-Burgos R., Chhoeu A.H., et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 65 7 (2007) 1321-1327
135. Goldstein M., Maxymiw W.G., Cummings B.J., et al. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 3 (1999) 365-373
136. Ichimura K., and Tanaka T. Trismus in patients with malignant tumours in the head and neck. J Laryngol Otol 107 11 (1993) 1017-1020
137. Steelman R., and Sokol J. Quantification of trismus following irradiation of the temporomandibular joint. Mo Dent J 66 6 (1986) 21-23
138. Benchalal M., Bachaud J.M., Francois P., et al. Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study. Radiother Oncol 36 3 (1995) 203-210
139. Bertrand J., Luc B., Philippe M., et al. Anterior mandibular osteotomy for tumor extirpation: a critical evaluation. Head Neck 22 4 (2000) 323-327
140. Nichol A.M., Smith S.L., D'Yachkova Y., et al. Quantification of masticatory muscle atrophy after high-dose radiotherapy. Int J Radiat Oncol Biol Phys 56 4 (2003) 1170-1179
141. Wang C.J., Huang E.Y., Hsu H.C., et al. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115 8 (2005) 1458-1460
142. Bentzen S.M., Thames H.D., and Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 15 3 (1989) 267-274
143. Martin M., Lefaix J.L., Pinton P., et al. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 134 1 (1993) 63-70
144. Wegrowski J., Lefaix J.L., and Lafuma C. Accumulation of glycosaminoglycans in radiation-induced muscular fibrosis. Int J Radiat Biol 61 5 (1992) 685-693
145. Dijkstra P.U., Huisman P.M., and Roodenburg J.L. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35 4 (2006) 337-342
146. Chua D.T., Lo C., Yuen J., et al. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24 4 (2001) 366-369
147. Nguyen T.D., Panis X., Froissart D., et al. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int J Radiat Oncol Biol Phys 14 1 (1988) 23-25
148. Shah S., Har-El G., and Rosenfeld R.M. Short-term and long-term quality of life after neck dissection. Head Neck 23 11 (2001) 954-961
149. Weymuller E.A., Yueh B., Deleyiannis F.W., et al. Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126 3 (2000) 329-335 [discussion: 35-6]